ETHZilla Corp — Director's Dealing 2023

May 19, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2023-05-18

Reporting Person: Pamir Ozan (CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-18	Common Stock	P	5162.077	$1.01	Acquired	8983.077	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $0.9801 to $1.02, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.